MARC details
000 -LEADER |
fixed length control field |
03089 a2200409 4500 |
001 - CONTROL NUMBER |
control field |
26002 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
TR-AnTOB |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240927104042.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
161010bs2006 tu ka b 000 0 |
015 ## - NATIONAL BIBLIOGRAPHY NUMBER |
National bibliography number |
GBA601442 |
Source |
bnb |
016 ## - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
013348527 |
Source |
Uk |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0521858224 (hbk.) |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
9780521858229 (hbk.) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)OCM62475370 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
UKM |
Transcribing agency |
UKM |
Modifying agency |
BAKER |
-- |
BWKUK |
-- |
OrLoB-B |
-- |
TR-AnTOB |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
İngilizce |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 736 |
Item number |
K73 2006 |
096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
Classification number |
QV736 K73 2006 |
245 00 - TITLE STATEMENT |
Title |
Knowledge accumulation and industry evolution : |
Remainder of title |
the case of Pharma-Biotech / |
Statement of responsibility, etc. |
edited by Mariana Mazzucato and Giovanni Dosi. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Cambridge, UK ; |
-- |
New York : |
Name of producer, publisher, distributor, manufacturer |
Cambridge University Press, |
Date of production, publication, distribution, manufacture, or copyright notice |
2006. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xvii, 446 p. : |
Other physical details |
ill. ; |
Dimensions |
24 cm. |
336 ## - CONTENT TYPE |
Source |
rdacontent |
Content type term |
text |
Content type code |
txt |
337 ## - MEDIA TYPE |
Source |
rdamedia |
Media type term |
unmediated |
Media type code |
n |
338 ## - CARRIER TYPE |
Source |
rdacarrier |
Carrier type term |
volume |
Carrier type code |
nc |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
|
505 #0 - FORMATTED CONTENTS NOTE |
Miscellaneous information |
1. |
-- |
2. |
-- |
3. |
-- |
4. |
-- |
5. |
-- |
6. |
-- |
7. |
-- |
8. |
-- |
9. |
-- |
10. |
-- |
11. |
-- |
12. |
-- |
13. |
-- |
14. |
Statement of responsibility |
Giovanni Dosi and Mariana Mazzucato -- |
-- |
Frank R. Lichtenberg -- |
-- |
Paul Nightingale and Surya Mahdi -- |
-- |
Myriam Mariani -- |
-- |
Louis Galambos -- |
-- |
Elena Cefis, Matteo Ciccarelli and Luigi Orsenigo -- |
-- |
Giulio Bottazzi, Fabio Pammolli and Angelo Secchi -- |
-- |
Christian Garavaglia, Franco Malerba and Luigi Orsenigo -- |
-- |
Boyan Jovanovic -- |
-- |
John P. Walsh, Ashish Arora and Wesley M. Cohen -- |
-- |
Fabienne Orsi, Christine Sevilla and Benjamin Coriat -- |
-- |
Pierre Regibeau and Katharine Rockett -- |
-- |
Joyce Tait, Joanna Chataway, Catherine Lyall and David Wield -- |
-- |
Luigi Orsenigo, Giovanni Dosi and Mariana Mazzucato. |
Title |
Introduction / |
-- |
Pharmaceutical innovation as a process of creative destruction / |
-- |
The evolution of pharmaceutical innovation / |
-- |
Firm and regional determinants in innovation models : evidence from biotechnology and traditional chemicals / |
-- |
Innovation and industry evolution : a comment / |
-- |
Heterogeneity and firm growth in the pharmaceutical industry / |
-- |
Growth and diversification patterns of the worldwide pharmaceutical industry / |
-- |
Entry, market structure, and innovation in a "history-friendly" model of the evolution of the pharmaceutical industry / |
-- |
The growth of pharmaceutical firms : a comment / |
-- |
The effects of research tool patents and licensing on biomedical innovation / |
-- |
Upstream patents and public health : the case of genetic testing for breast cancer / |
-- |
Competition, regulation, and intellectual property management in genetically modified foods : evidence from survey data / |
-- |
Governance, policy, and industry strategies : pharmaceuticals and agro-biotechnology / |
-- |
The dynamics of knowledge accumulation, regulation, and appropriability in the pharma-biotech sector : policy issues / |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug Industry |
9 (RLIN) |
23084 |
|
Topical term or geographic name entry element |
Biomedical Research |
9 (RLIN) |
128330 |
|
Topical term or geographic name entry element |
Biomedical Technology |
9 (RLIN) |
128329 |
|
Topical term or geographic name entry element |
Technology, Pharmaceutical |
9 (RLIN) |
23088 |
|
Topical term or geographic name entry element |
Economics, Pharmaceutical |
9 (RLIN) |
23086 |
700 ## - ADDED ENTRY--PERSONAL NAME |
Personal name |
Mazzucato, Mariana, |
Dates associated with a name |
1968- |
9 (RLIN) |
23082 |
|
Personal name |
Dosi, Giovanni |
9 (RLIN) |
23083 |
902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
a |
0014629 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Book |
Source of classification or shelving scheme |
National Library of Medicine |